Ischemic Stroke Causes Disruptions in the Carnitine Shuttle System

Gaining a deep understanding of the molecular mechanisms underlying ischemic stroke is necessary to develop treatment alternatives. Ischemic stroke is known to cause a cellular energy imbalance when glucose supply is deprived, enhancing the role for energy production via β-oxidation where acylcarnit...

Full description

Bibliographic Details
Main Authors: Leonidas Mavroudakis, Ingela Lanekoff
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Metabolites
Subjects:
Online Access:https://www.mdpi.com/2218-1989/13/2/278
_version_ 1797619296728252416
author Leonidas Mavroudakis
Ingela Lanekoff
author_facet Leonidas Mavroudakis
Ingela Lanekoff
author_sort Leonidas Mavroudakis
collection DOAJ
description Gaining a deep understanding of the molecular mechanisms underlying ischemic stroke is necessary to develop treatment alternatives. Ischemic stroke is known to cause a cellular energy imbalance when glucose supply is deprived, enhancing the role for energy production via β-oxidation where acylcarnitines are essential for the transportation of fatty acids into the mitochondria. Although traditional bulk analysis methods enable sensitive detection of acylcarnitines, they do not provide information on their abundances in various tissue regions. However, with quantitative mass spectrometry imaging the detected concentrations and spatial distributions of endogenous molecules can be readily obtained in an unbiased way. Here, we use pneumatically assisted nanospray desorption electrospray ionization mass spectrometry imaging (PA nano-DESI MSI) doped with internal standards to study the distributions of acylcarnitines in mouse brain affected by stroke. The internal standards enable quantitative imaging and annotation of endogenous acylcarnitines is achieved by studying fragmentation patterns. We report a significant accumulation of long-chain acylcarnitines due to ischemia in brain tissue of the middle cerebral artery occlusion (MCAO) stroke model. Further, we estimate activities of carnitine transporting enzymes and demonstrate disruptions in the carnitine shuttle system that affects the β-oxidation in the mitochondria. Our results show the importance for quantitative monitoring of metabolite distributions in distinct tissue regions to understand cell compensation mechanisms involved in handling damage caused by stroke.
first_indexed 2024-03-11T08:26:07Z
format Article
id doaj.art-4aab8a88117f4baca21252a10f86fdea
institution Directory Open Access Journal
issn 2218-1989
language English
last_indexed 2024-03-11T08:26:07Z
publishDate 2023-02-01
publisher MDPI AG
record_format Article
series Metabolites
spelling doaj.art-4aab8a88117f4baca21252a10f86fdea2023-11-16T22:05:22ZengMDPI AGMetabolites2218-19892023-02-0113227810.3390/metabo13020278Ischemic Stroke Causes Disruptions in the Carnitine Shuttle SystemLeonidas Mavroudakis0Ingela Lanekoff1Department of Chemistry—BMC, Uppsala University, 75237 Uppsala, SwedenDepartment of Chemistry—BMC, Uppsala University, 75237 Uppsala, SwedenGaining a deep understanding of the molecular mechanisms underlying ischemic stroke is necessary to develop treatment alternatives. Ischemic stroke is known to cause a cellular energy imbalance when glucose supply is deprived, enhancing the role for energy production via β-oxidation where acylcarnitines are essential for the transportation of fatty acids into the mitochondria. Although traditional bulk analysis methods enable sensitive detection of acylcarnitines, they do not provide information on their abundances in various tissue regions. However, with quantitative mass spectrometry imaging the detected concentrations and spatial distributions of endogenous molecules can be readily obtained in an unbiased way. Here, we use pneumatically assisted nanospray desorption electrospray ionization mass spectrometry imaging (PA nano-DESI MSI) doped with internal standards to study the distributions of acylcarnitines in mouse brain affected by stroke. The internal standards enable quantitative imaging and annotation of endogenous acylcarnitines is achieved by studying fragmentation patterns. We report a significant accumulation of long-chain acylcarnitines due to ischemia in brain tissue of the middle cerebral artery occlusion (MCAO) stroke model. Further, we estimate activities of carnitine transporting enzymes and demonstrate disruptions in the carnitine shuttle system that affects the β-oxidation in the mitochondria. Our results show the importance for quantitative monitoring of metabolite distributions in distinct tissue regions to understand cell compensation mechanisms involved in handling damage caused by stroke.https://www.mdpi.com/2218-1989/13/2/278acylcarnitinesmass spectrometry imagingischemic strokenano-DESI
spellingShingle Leonidas Mavroudakis
Ingela Lanekoff
Ischemic Stroke Causes Disruptions in the Carnitine Shuttle System
Metabolites
acylcarnitines
mass spectrometry imaging
ischemic stroke
nano-DESI
title Ischemic Stroke Causes Disruptions in the Carnitine Shuttle System
title_full Ischemic Stroke Causes Disruptions in the Carnitine Shuttle System
title_fullStr Ischemic Stroke Causes Disruptions in the Carnitine Shuttle System
title_full_unstemmed Ischemic Stroke Causes Disruptions in the Carnitine Shuttle System
title_short Ischemic Stroke Causes Disruptions in the Carnitine Shuttle System
title_sort ischemic stroke causes disruptions in the carnitine shuttle system
topic acylcarnitines
mass spectrometry imaging
ischemic stroke
nano-DESI
url https://www.mdpi.com/2218-1989/13/2/278
work_keys_str_mv AT leonidasmavroudakis ischemicstrokecausesdisruptionsinthecarnitineshuttlesystem
AT ingelalanekoff ischemicstrokecausesdisruptionsinthecarnitineshuttlesystem